| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Passage Bio, Inc. (PASG) has 4 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. PASG is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.07M | $35.49M | - | |
| 10% | 623.7K | $3.65M | - | |
| CEO | 10.6K | $62.0K | - | |
| CFO | 7.5K | $43.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2020 | Frazier Life Sciences Ix, L.P. | 10% Owner | Buy | 550,000 | $18.00 | $9,900,000.00 | +12.3% | |
| Mar 3, 2020 | Heron Patrick J87 | Director, 10% Owner | Buy | 550,000 | $18.00 | $9,900,000.00 | +12.3% | |
| Mar 3, 2020 | Woiwode Thomas | Director, 10% Owner | Buy | 225,000 | $18.00 | $4,050,000.00 | +31.8% | |
| Mar 3, 2020 | Kapadia Sandip71 | Director | Buy | 5,000 | $18.00 | $90,000.00 | New | |
| Mar 3, 2020 | Countouriotis Athena | Director | Buy | 8,900 | $18.00 | $160,200.00 | New | |
| Mar 3, 2020 | Ratcliffe Liam86 | Director | Buy | 2,800 | $18.00 | $50,400.00 | New | |
| Mar 3, 2020 | Yamada Tadataka | Director | Buy | 6,500 | $18.00 | $117,000.00 | +1.0% | |
| Mar 3, 2020 | Versant Venture Capital Vi, L.P.66 | 10% Owner | Buy | 225,000 | $18.00 | $4,050,000.00 | +31.8% | |
| Mar 3, 2020 | Quigley Jill M.63 | Chief Operating Officer | Buy | 2,500 | $18.00 | $45,000.00 | +0.8% | |
| Mar 3, 2020 | Goldsmith Bruce A | CEO And President | Buy | 1,100 | $18.00 | $19,800.00 | New |